134 related articles for article (PubMed ID: 7487122)
1. [Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil].
Yuasa C; Okabe H; Toko T; Takeda S; Unemi N
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1927-32. PubMed ID: 7487122
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of the chemotherapeutic effectiveness of UFT, a combination of tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral l-leucovorin.
Okabe H; Toko T; Saito H; Nakano K; Fujioka A; Yuasa C; Takeda S; Unemi N
Anticancer Res; 1997; 17(1A):157-64. PubMed ID: 9066646
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy with orally administered UFT and leucovorin (LV)].
Okabe H; Saito H; Oie S; Nakano K; Uchida J; Takechi T; Takeda S; Kawaguchi Y; Taguchi T
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1645-50. PubMed ID: 1872623
[TBL] [Abstract][Full Text] [Related]
4. [Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--growth-inhibitory activity of combination against human tumor xenograft].
Saito H; Okabe H; Nakano K; Fujioka A; Toko T; Takeda S; Unemi N
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1919-25. PubMed ID: 7487121
[TBL] [Abstract][Full Text] [Related]
5. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N
J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/ LV.
Ito Y; Nakanishi H; Kodera Y; Hirai T; Nakao A; Kato T
Cancer Sci; 2010 Aug; 101(8):1853-60. PubMed ID: 20500514
[TBL] [Abstract][Full Text] [Related]
7. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
[TBL] [Abstract][Full Text] [Related]
8. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
[TBL] [Abstract][Full Text] [Related]
9. Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid.
Moran RG; Scanlon KL
Cancer Res; 1991 Sep; 51(17):4618-23. PubMed ID: 1831402
[TBL] [Abstract][Full Text] [Related]
10. Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines.
Tsai CM; Hsiao SH; Frey CM; Chang KT; Perng RP; Gazdar AF; Kramer BS
Cancer Res; 1993 Mar; 53(5):1079-84. PubMed ID: 8382553
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
12. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I
Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study of biochemical modulation of 5-fluorouracil with l-leucovorin against human esophageal cancer].
Terashima M; Ikeda K; Kawamura H; Maesawa C; Takiyama I; Yoshinari H; Koeda K; Sato N; Ishida K; Saito K
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1999-2004. PubMed ID: 1417007
[TBL] [Abstract][Full Text] [Related]
15. A study of various strategies to enhance the cytotoxic activity of 5-fluorouracil/leucovorin in human colorectal cancer cell lines.
Scheithauer W; Temsch EM
Anticancer Res; 1989; 9(6):1793-8. PubMed ID: 2627128
[TBL] [Abstract][Full Text] [Related]
16. [A case of hepatic metastases of sigmoid colon cancer which completely responded to systemic l-leucovorin/5-FU therapy and oral LV/UFT combination therapy].
Ishii Y; Takahashi M; Ishigame T; Okayama H
Gan To Kagaku Ryoho; 2006 May; 33(5):675-8. PubMed ID: 16685171
[TBL] [Abstract][Full Text] [Related]
17. Preliminary study of the optimal dosing schedule for oral UFT/leucovorin chemotherapy.
Sadahiro S; Suzuki T; Ishikawa K; Nakamura T; Saguchi T; Kamijo A; Yasuda S; Makuuchi H; Murayama C
Anticancer Res; 2004; 24(2B):625-30. PubMed ID: 15161004
[TBL] [Abstract][Full Text] [Related]
18. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
[TBL] [Abstract][Full Text] [Related]
19. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells.
Tillman DM; Petak I; Houghton JA
Clin Cancer Res; 1999 Feb; 5(2):425-30. PubMed ID: 10037193
[TBL] [Abstract][Full Text] [Related]
20. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
Petak I; Tillman DM; Houghton JA
Clin Cancer Res; 2000 Nov; 6(11):4432-41. PubMed ID: 11106264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
